Antioxidants and Redox Signaling

Journal Title

  • Antioxidants and Redox Signaling

ISSN

  • E 1557-7716 | P 1523-0864 | 1523-0864 | 1557-7716

Publisher

  • Mary Ann Liebert Inc.
  • Mary Ann Liebert

Listed on(Coverage)

JCR2003-2019
SJR2000-2019
CiteScore2011-2019
SCI2010-2019
SCIE2010-2021
CC2016-2021
SCOPUS2017-2020
MEDLINE2016-2021
EMBASE2016-2020

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • USA

Aime & Scopes

  • Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas. ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes. ARS coverage includes: /// ROS/RNS as messengers /// Gaseous signal transducers /// Hypoxia and tissue oxygenation /// microRNA /// Prokaryotic systems /// Lessons from plant biology

Article List

1 - 2 out of 2 results.

1

BROWSE